China Money Network
Login
Join

Chinese Bio-pharmaceutical Company TOT Biopharm Raises $102M Series B Round

  • August 10, 2018 — 11:53 CST

This Data Is Locked!

This area is available only to Subscribers.

Suzhou-based bio-pharmaceutical company TOT Biopharm has raised US$102 million series B round led by Chinese local asset management 99Fund, according to the company’s announcement. Existing... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: